A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic … FCC van Rhijn-Brouwer, H Gremmels, JO Fledderus, AH Schuurman, ... BMJ open 8 (8), e020479, 2018 | 30 | 2018 |
Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia JGJ Wijnand, M Teraa, H Gremmels, FCC van Rhijn-Brouwer, GJ de Borst, ... Journal of vascular surgery 67 (2), 656-661, 2018 | 29 | 2018 |
Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy FCC van Rhijn-Brouwer, H Gremmels, JO Fledderus, MC Verhaar Cell transplantation 27 (5), 765-785, 2018 | 25 | 2018 |
Cellular therapies in systemic sclerosis: recent progress FCC van Rhijn-Brouwer, H Gremmels, JO Fledderus, TRD Radstake, ... Current Rheumatology Reports 18 (2), 1-13, 2016 | 24 | 2016 |
Resetting the T cell compartment in autoimmune diseases with autologous hematopoietic stem cell transplantation: an update L Lutter, J Spierings, F van Rhijn-Brouwer, J van Laar, F Van Wijk Frontiers in Immunology 9, 767, 2018 | 22 | 2018 |
Hematopoietic stem-cell transplantation in systemic sclerosis: an update J Spierings, FCC van Rhijn-Brouwer, JM van Laar Current opinion in rheumatology 30 (6), 541-547, 2018 | 19 | 2018 |
Structure and Function of RNase AS, a Polyadenylate-Specific Exoribonuclease Affecting Mycobacterial Virulence In Vivo M Romano, R van de Weerd, FCC Brouwer, GN Roviello, R Lacroix, ... Structure 22 (5), 2014 | 18 | 2014 |
Paracrine proangiogenic function of human bone marrow‐derived mesenchymal stem cells is not affected by chronic kidney disease FCC van Rhijn-Brouwer, BWM van Balkom, DA Papazova, ... Stem cells international 2019 (1), 1232810, 2019 | 17 | 2019 |
Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective J Spierings, FCC van Rhijn-Brouwer, CJM de Bresser, PTM Mosterman, ... Rheumatology 59 (8), 2052-2061, 2020 | 14 | 2020 |
Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance? FCC van Rhijn-Brouwer, J Spierings, JM van Laar Immunology letters 195, 88-96, 2018 | 12 | 2018 |
Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model FCCC van Rhijn-Brouwer, H Gremmels, K Den Ouden, M Teraa, ... Stem Cells and Development 31 (7-8), 176-180, 2022 | 5 | 2022 |
From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation J Spierings, CJM de Bresser, FCC van Rhijn-Brouwer, A Pieterse, ... Journal of Scleroderma and Related Disorders 5 (3), 202-209, 2020 | 5 | 2020 |
Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report FCC van Rhijn-Brouwer, J Spierings, A van Rhenen, J Kuball, ... Rheumatology (Oxford, England) 58 (7), 1305, 2019 | 5 | 2019 |
Nailfold capillaroscopy in patients with peripheral artery disease of the lower limb (CAPAD study) JGJ Wijnand, FCC van Rhijn-Brouwer, J Spierings, M Teraa, GJ de Borst, ... European Journal of Vascular and Endovascular Surgery 63 (6), 900-901, 2022 | 4 | 2022 |
Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia H Gremmels, FCC van Rhijn-Brouwer, DA Papazova, JO Fledderus, ... Angiogenesis 22 (3), 411-420, 2019 | 4 | 2019 |
Graded exercise therapy should not be recommended for patients with post-exertional malaise FCCC van Rhijn-Brouwer, M Hellemons, M Stingl, K Hoffmann, ... Nature Reviews Cardiology, 1-2, 2024 | 3 | 2024 |
Consensusdocument: Autologe hematopoïetische stamceltransplantatie bij ernstige diffuse cutane systemische sclerose FC van Rhijn-Brouwer, MC Vonk, W van der Velden, AE Voskuyl, ... | 2 | 2016 |
Systematic review and meta-analysis of the effect of bone marrow-derived cell therapies on hind limb perfusion FCCC van Rhijn-Brouwer, KE Wever, R Kiffen, JR van Rhijn, H Gremmels, ... Disease Models & Mechanisms 17 (5), 2024 | 1 | 2024 |
De ASTIS-studie: autologe stamcel-transplantatie versus intraveneus ‘pulse’cyclofosfamide bij diffuse cutane systemische sclerose; een gerandomiseerde klinische studie JK De Vries-Bouwstra, FCC Van Rhijn-Brouwer, JK Sont, EWA Marijt, ... Ned Tijdschr Hematol 13, 219-32, 2016 | 1 | 2016 |
The effect of bone marrow derived cell therapies on hind limb perfusion, A systematic review and meta-analysis FCC van Rhijn-Brouwer, KE Wever, R Kiffen, JR van Rhijn, H Gremmels, ... Disease Models & Mechanisms, dmm. 050632, 2024 | | 2024 |